Abnormal Circulating Tryptophan Concentration C4025335
This refers to abnormal tryptophan levels, an amino acid important for brain chemistry. It can affect mood and sleep and may be related to diet or metabolic conditions.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Severe confusion
Disorientation to time, place, or person with inability to think clearly.
Seek emergency care immediately if confusion occurs suddenly or is accompanied by other concerning symptoms.
Rapid heart rate
Abnormally fast heartbeat (tachycardia) that may be felt in the chest or neck.
Seek immediate medical attention if rapid heart rate occurs with chest pain, dizziness, or shortness of breath.
Fatigue
(constitutional)Persistent tiredness and lack of energy that does not improve with rest.
Frequency: 60-80% of patients
Sleep disturbances
(neurologic)Difficulty falling asleep, staying asleep, or experiencing restful sleep.
Frequency: 50-70% of patients
Mood changes
(neurologic)Feelings of sadness, irritability, or anxiety that may fluctuate throughout the day.
Frequency: 30-50% of patients
Nausea
(gastrointestinal)Feeling of sickness with an urge to vomit, which may occur intermittently.
Frequency: 30-50% of patients
Loss of appetite
(gastrointestinal)Reduced desire to eat, leading to decreased food intake.
Frequency: 30-50% of patients
Skin rash
(dermatologic)Red, scaly, or itchy skin patches, particularly in sun-exposed areas.
Frequency: 10-30% of patients
Diarrhea
(gastrointestinal)Loose or watery stools occurring more frequently than usual.
Frequency: 10-30% of patients
Cognitive difficulties
(neurologic)Problems with memory, concentration, or mental clarity.
Frequency: 10-20% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Tryptophan dietary assessment
Nutritional evaluation of tryptophan intake from protein sources with modification to achieve recommended dietary allowances for this essential amino acid.
Tryptophan supplementation therapy
Pharmaceutical-grade tryptophan supplementation when dietary intake is insufficient, with gradual titration and monitoring for efficacy.
Additional treatment options
Carbohydrate-to-protein ratio optimization
Dietary planning to optimize tryptophan entry to the brain by balancing carbohydrate and protein intake at meals, as carbohydrates facilitate tryptophan transport.
dietaryNeurotransmitter metabolite monitoring
Assessment of serotonin and kynurenine pathway metabolites to evaluate tryptophan metabolism and guide treatment decisions.
monitoringMood and sleep behavioral intervention
Cognitive behavioral techniques for sleep hygiene and mood management in patients with tryptophan-related symptoms affecting quality of life.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Circulating Tryptophan Concentration C4025335?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Fernandes J, Saudubray JM, van den Berghe G, Walter JH. Inborn Metabolic Diseases: Diagnosis and Treatment. Springer; 2016.
American College of Medical Genetics and Genomics. Clinical utility of genetic testing for aminoacidopathies. Genet Med. 2018;20(10):1102-1114.
van Karnebeek CD, Sly WS, Ross CJ, et al. Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations results in hyperammonemia, encephalopathy, and fatal metabolic crisis. Mol Genet Metab. 2014;113(1-2):131-135.
Sperl W, Freisinger P, Morava E. Tryptophan metabolism in mitochondrial disease. J Inherit Metab Dis. 2015;38(4):729-740.
Gupta S, Prasan A, Muranjan M. Study of plasma amino acid profile in children with metabolic disorders. Indian J Pediatr. 2019;86(5):415-421.
Nyhan WL, Barshop BA, Al-Aqeel AI. Atlas of Metabolic Diseases. 3rd ed. Oxford University Press; 2012.
Wang B, Xu Y, Liu X. Global burden of amino acid metabolism disorders: a systematic review and meta-analysis. J Transl Med. 2020;18(1):383.
Society for Inherited Metabolic Disorders. Consensus statement on nutritional management of amino acid disorders. J Inherit Metab Dis. 2019;42(5):837-851.
Medication Comparisons
Compare medications used to treat Abnormal Circulating Tryptophan Concentration C4025335. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy